Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CHKA | P35790 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20160922 | 0.98 | NR3C2 (0.53) | NR3C2ALDH1A1MAPTHPGDTAAR1 | |
| SCHEMBL18377018 | 0.98 | NR3C2 (0.53) | NR3C2ALDH1A1MAPTHPGDTAAR1 | |
| SCHEMBL3368539 | 0.95 | NR3C2 (0.55) | NR3C2ALDH1A1MAPTHPGDTAAR1 | |
| SCHEMBL6932587 | 0.93 | NR3C2 (0.52) | NR3C2ALDH1A1MAPTHPGDTAAR1 | |
| SCHEMBL13241976 | 0.92 | CYP2C19 (0.46) | NR3C2ALDH1A1MAPTHPGDTAAR1 | |
| SCHEMBL20681739 | 0.91 | NR3C2 (0.51) | NR3C2ALDH1A1MAPTHPGDTAAR1 | |
| SCHEMBL21390743 | 0.90 | NR3C2 (0.47) | NR3C2ALDH1A1MAPTHPGDTAAR1 | |
| SCHEMBL7149333 | 0.87 | NR3C2 (0.60) | NR3C2ALDH1A1MAPTKDM4EL3MBTL1 | |
| SCHEMBL13352434 | 0.87 | NR3C2 (0.41) | NR3C2ALDH1A1MAPTHPGDTAAR1 | |
| SCHEMBL12763736 | 0.86 | NR3C2 (0.47) | NR3C2ALDH1A1MAPTHPGDTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11329232-B2 | Arylamine-based compound including thermally decomposable groups and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-10 | — | — | US | disclosed |
| WO-2020248755-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND PHOTOELECTRIC CONVERSION DEVICE | 陕西莱特光电材料股份有限公司 | 2020-12-17 | — | — | WO | disclosed |
| US-20190326519-A1 | ARYLAMINE-BASED COMPOUND INCLUDING THERMALLY DECOMPOSABLE GROUPS AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-24 | — | — | US | disclosed |
| US-20160211456-A1 | PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF | LUMINESCENCE TECHNOLOGY CORP. | 2016-07-21 | — | — | US | disclosed |
| EP-0556612-A1 | Synergistic stabilizer compositions for polyols and polyurethane foam | R.T. VANDERBILT COMPANY, Inc. (US) | 1993-08-25 | — | — | EP | disclosed |
| US-5156762-A | 2,6-Di-tert-butyl-4-sec-butylphenol, phenothiazine or alkyl-substitued derivative, and reaction product of styrene, diisobutylene and diphenylamine | R. T. VANDERBILT COMPANY, INC. (US) | 1992-10-20 | — | — | US | disclosed |
| US-5143943-A | 2,6-di-tert-butyl-4-sec-butylphenol; reaction product of styrene, diphenylamine, and diisobutylene; and phenothiazine compound; discoloration inhibition | R. T. VANDERBILT COMPANY, INC. (US) | 1992-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190326519-A1 | ARYLAMINE-BASED COMPOUND INCLUDING THERMALLY DECOMPOSABLE GROUPS AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AHR, NAT1, TYR | NR3C2 3704/4885ALDH1A1 39/4885MAPT 912/4885 |
| US-11329232-B2 | Arylamine-based compound including thermally decomposable groups and organic light-emitting device including the same | AHR, NAT1, TYR | NR3C2 3704/4885ALDH1A1 39/4885MAPT 912/4885 |
| US-20160211456-A1 | PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF | POP1, TERB1, AP2B1 | NR3C2 949/4885ALDH1A1 2052/4885MAPT 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.